The animal model market is a critical segment within the biomedical research industry, driving innovations in drug development, toxicity testing, and disease modeling. This market is increasingly influenced by advanced technological integration and stringent regulatory environments, shaping the trajectory of market growth and business revenue streams.
Market Size and Overview
The global animal model market was valued at US$ 1,577.30 Mn in 2021 and is forecast to reach a value of US$ 2,394.30 Mn by 2028 at a CAGR of 6.0% between 2022 and 2028.
This steady market growth is propelled by increasing demand for precise disease models and rising investments in preclinical research. Recent market insights emphasize the expansion of novel genetically modified models that cater to complex disease studies, broadening the Animal Model Market Scope and reinforcing market revenue potential.
Market Drivers
A key market driver for the Animal Model Market is the surge in pharmaceutical R&D expenditure, which climbed significantly in 2024. For instance, global pharmaceutical companies increased their clinical pipeline and preclinical study budgets by over 8%, intensifying reliance on animal models for efficacy and safety assessment. This driver is shaping the market dynamics by stimulating innovation across market segments, thus providing substantial market opportunities despite existing market restraints related to ethical concerns and regulatory compliance.
PEST Analysis
- Political: Increasing government support and funding for biomedical research in regions like North America and Europe have positively impacted the animal model market. Regulatory bodies are evolving guidelines to balance ethical considerations with scientific advancement, influencing market policies and compliance requirements in 2024.
- Economic: The rising healthcare expenditure worldwide, coupled with increased biopharmaceutical investments, notably in Asia-Pacific, is driving demand and expanding the industry size. Inflationary trends are moderately challenging but managed by strategic pricing and operational efficiencies.
- Social: There is growing public scrutiny on animal testing; however, awareness campaigns and the development of alternative models have accelerated acceptance of refined animal models, reducing social resistance and expanding market share in ethical research sectors.
- Technological: Technological advancements, including CRISPR gene editing and improved imaging techniques introduced in 2025, are enhancing the accuracy and reliability of animal models, fostering strong market growth strategies and reinforcing industry trends toward precision research models.
Promotion and Marketing Initiatives
Leading market players are increasingly leveraging strategic partnerships and digital platforms to educate stakeholders and enhance market revenue. For example, a key company launched an interactive virtual laboratory platform in early 2025 that allows pharmaceutical customers to simulate animal model experiments, significantly boosting user engagement and driving business growth. Such innovative marketing initiatives highlight the emphasis on transparency and client-centric approaches, positively impacting market insights and future market opportunities.
Key Players
Prominent companies within the animal model market include:
- Charles River Laboratories International
- Envigo RMS
- Taconic Biosciences
- Jackson Laboratory
- Crown Bioscience
- Biomere, Inc.
- Labcorp
- WuXi AppTec
- Inotiv
- SAGE Labs
- Pharmaron
- Harlan Laboratories
Recent market growth strategies adopted by these players involve:
- Expansion of genetically engineered model portfolios to meet rising demand for disease-specific models in 2025.
- Strategic acquisitions to increase geographic footprint and expand service offerings, such as Charles River’s acquisition moves reported in 2024 which boosted company’s market share and revenue streams.
- Launch of integrated preclinical CRO services focusing on accelerated drug discovery pipelines, enhancing competitive positioning and industry share.
FAQs
Q1: Who are the dominant players in the animal model market?
Dominant market players include Charles River Laboratories International, Envigo RMS, and Taconic Biosciences, all recognized for extensive product portfolios and expansion strategies in 2024 and 2025 that solidify their market position.
Q2: What will be the size of the animal model market in the coming years?
The animal model market size is projected to grow from USD 1,577.30 million in 2025 to about USD 2,394.30 million by 2032, reflecting a CAGR of 6.0%.
Q3: Which end-user industry has the largest growth opportunity?
Pharmaceutical and biotechnology companies present the largest growth opportunity due to increasing R&D investment and demand for advanced preclinical testing models.
Q4: How will market development trends evolve over the next five years?
Market trends indicate increased adoption of genetically engineered models and integration of AI technologies to enhance predictive capabilities, driving market dynamics and opening new market segments.
Q5: What is the nature of the competitive landscape and challenges in the animal model market?
The competitive landscape is characterized by innovation-driven strategies, acquisitions, and partnerships. Key challenges include regulatory restraints and ethical considerations, leading to a focus on developing alternative and refined animal models.
Q6: What go-to-market strategies are commonly adopted in the animal model market?
Common strategies involve digital transformation initiatives, collaborative partnerships with research institutions, and broadening service portfolios to offer comprehensive preclinical solutions, effectively enhancing market share and revenue growth.
‣ Get more insights on : Animal Model Market
‣ Get this Report in Japanese Language: 動物模型市場
‣ Get this Report in Korean Language: 동물모델시장
‣ Read More Articles Related to this Industry: Key Challenges in Implementing Liquid Biopsy in Clinical Practice
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)